|
|
|
| Healthcare Corporate Finance News | |
 |
Market Intelligence on Health Care Venture Capital, M&A, Private Equity, and IPOs |
 |
|
|
Home | Publications | Resource Center | Database | Free Trials | Conference | Order | Senior Care Blog | Search | Contact Us 1-800-248-1668 |
|
|
VC Advantage Health Care Venture Capital News from Healthcare Corporate Finance News Written by: Gretchen Swanson, Editor of the Healthcare Corporate Finance News |
|
|||
Biopharm and Biotech Garner Most Deals, Most Dollars (June 16, 2006)Including two deals closed by companies that provide health care information technology solutions, a total of 15 health care venture capital investments amounting to more than $276 million were announced during the first half of June 2006. The biopharmaceutical and biotechnology sectors each accounted for more than 25% of the total dollars, in a combined total of seven transactions, including the two largest in the past two weeks. The following are the top five health care venture capital transactions, by dollar amount, for this period. CoGenesys, Inc., a biopharma founded by former senior executives of one of its investors, Human Genome Sciences, Inc., raised $55 million in a Series A financing led by New Enterprise Associates and including OrbiMed Advisors and Red Abbey Venture Partners. Asuragen, Inc., a biotech spun off from Ambion, Inc., raised $49 million from Telegraph Hill Partners (lead) and other investors. Two pharmaceutical companies announced the two next-largest deals for the period. TetraLogic Pharmaceuticals secured a $36 million B round from investors led by Latterell Venture Partners and including Quaker BioVentures, The Vertical Group and Amgen Ventures. Aegerion Pharmaceuticals closed on $22.5 million in Series B venture funding from Advent International, which led the round, Index Ventures, Alta Partners and MVM Life Science Partners. Lastly, Bridge Pharmaceuticals, a contract research organization, raised $22 million in Series B financing from a syndicate of unidentified investors based in the United States and Asia. Click here for a FREE TRIAL to the Healthcare Corporate Finance News
|